Velpandi Ayyavoo - Publications

University of Pittsburgh, Pittsburgh, PA, United States 
Molecular Biology, Immunology

39 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Venkatachari NJ, Jain S, Walker L, Bivalkar-Mehla S, Chattopadhyay A, Bar-Joseph Z, Rinaldo C, Ragin A, Seaberg E, Levine A, Becker J, Martin E, Sacktor N, Ayyavoo V. Transcriptome analyses identify key cellular factors associated with HIV-1 associated neuropathogenesis in infected men. Aids (London, England). PMID 28005686 DOI: 10.1097/QAD.0000000000001379  0.52
2016 Jain S, Arrais J, Venkatachari NJ, Ayyavoo V, Bar-Joseph Z. Reconstructing the temporal progression of HIV-1 immune response pathways. Bioinformatics (Oxford, England). 32: i253-i261. PMID 27307624 DOI: 10.1093/bioinformatics/btw254  0.52
2015 Venkatachari NJ, Zerbato JM, Jain S, Mancini AE, Chattopadhyay A, Sluis-Cremer N, Bar-Joseph Z, Ayyavoo V. Temporal transcriptional response to latency reversing agents identifies specific factors regulating HIV-1 viral transcriptional switch. Retrovirology. 12: 85. PMID 26438393 DOI: 10.1186/s12977-015-0211-3  0.52
2015 Zaccard CR, Watkins SC, Kalinski P, Fecek RJ, Yates AL, Salter RD, Ayyavoo V, Rinaldo CR, Mailliard RB. CD40L induces functional tunneling nanotube networks exclusively in dendritic cells programmed by mediators of type 1 immunity. Journal of Immunology (Baltimore, Md. : 1950). 194: 1047-56. PMID 25548234 DOI: 10.4049/jimmunol.1401832  0.32
2015 Zaccard CR, Watkins SC, Kalinski P, Fecek RJ, Yates AL, Salter RD, Ayyavoo V, Rinaldo CR, Mailliard RB. CD40L induces functional tunneling nanotube networks exclusively in dendritic cells programmed by mediators of type 1 immunity Journal of Immunology. 194: 1047-1056. DOI: 10.4049/jimmunol.1401832  0.52
2014 Zaccard CR, Watkins SC, Ayyavoo V, Rinaldo CR, Mailliard RB. HIV's ticket to ride: Cytotoxic T-lymphocyte-activated dendritic cells exploited for virus intercellular transfer. Aids Research and Human Retroviruses. 30: 1023-4. PMID 25354022 DOI: 10.1089/aid.2014.0218  0.52
2014 Srinivasan A, Rastogi A, Ayyavoo V, Srivastava S. Nanotechnology-based approaches for the development of diagnostics, therapeutics, and vaccines. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 33: 186-91. PMID 24937250 DOI: 10.1089/mab.2014.0045  0.52
2014 Thapa DR, Hussain SK, Tran WC, Dʼsouza G, Bream JH, Achenback CJ, Ayyavoo V, Detels R, Martínez-Maza O. Serum microRNAs in HIV-infected individuals as pre-diagnosis biomarkers for AIDS-NHL. Journal of Acquired Immune Deficiency Syndromes (1999). 66: 229-37. PMID 24675587 DOI: 10.1097/QAI.0000000000000146  0.52
2014 Hadi K, Walker LA, Guha D, Murali R, Watkins SC, Tarwater P, Srinivasan A, Ayyavoo V. Human immunodeficiency virus type 1 Vpr polymorphisms associated with progressor and nonprogressor individuals alter Vpr-associated functions. The Journal of General Virology. 95: 700-11. PMID 24300552 DOI: 10.1099/vir.0.059576-0  0.52
2013 Duskova K, Nagilla P, Le HS, Iyer P, Thalamuthu A, Martinson J, Bar-Joseph Z, Buchanan W, Rinaldo C, Ayyavoo V. MicroRNA regulation and its effects on cellular transcriptome in human immunodeficiency virus-1 (HIV-1) infected individuals with distinct viral load and CD4 cell counts. Bmc Infectious Diseases. 13: 250. PMID 23721325 DOI: 10.1186/1471-2334-13-250  0.52
2012 Gupta P, Ratner D, Ding M, Patterson B, Rohan LC, Reinhart TA, Ayyavoo V, Huang X, Patton DL, Ramratnam B, Cole AM. Retrocyclin RC-101 blocks HIV-1 transmission across cervical mucosa in an organ culture. Journal of Acquired Immune Deficiency Syndromes (1999). 60: 455-61. PMID 22592582 DOI: 10.1097/QAI.0b013e318258b420  0.52
2010 Venkatachari NJ, Walker LA, Tastan O, Le T, Dempsey TM, Li Y, Yanamala N, Srinivasan A, Klein-Seetharaman J, Montelaro RC, Ayyavoo V. Human immunodeficiency virus type 1 Vpr: oligomerization is an essential feature for its incorporation into virus particles. Virology Journal. 7: 119. PMID 20529298 DOI: 10.1186/1743-422X-7-119  0.52
2010 Schaubert KL, Price DA, Salkowitz JR, Sewell AK, Sidney J, Asher TE, Blondelle SE, Adams S, Marincola FM, Joseph A, Sette A, Douek DC, Ayyavoo V, Storkus W, Leung MY, et al. Generation of robust CD8+ T-cell responses against subdominant epitopes in conserved regions of HIV-1 by repertoire mining with mimotopes. European Journal of Immunology. 40: 1950-62. PMID 20432235 DOI: 10.1002/eji.200940079  0.52
2009 Venkatachari NJ, Alber S, Watkins SC, Ayyavoo V. HIV-1 infection of DC: evidence for the acquisition of virus particles from infected T cells by antigen uptake mechanism. Plos One. 4: e7470. PMID 19829715 DOI: 10.1371/journal.pone.0007470  0.52
2009 Majumder B, Venkatachari NJ, Srinivasan A, Ayyavoo V. HIV-1 mediated immune pathogenesis: spotlight on the role of viral protein R (Vpr). Current Hiv Research. 7: 169-77. PMID 19275586 DOI: 10.2174/157016209787581445  0.52
2008 Srinivasan A, Ayyavoo V, Mahalingam S, Kannan A, Boyd A, Datta D, Kalyanaraman VS, Cristillo A, Collman RG, Morellet N, Sawaya BE, Murali R. A comprehensive analysis of the naturally occurring polymorphisms in HIV-1 Vpr: potential impact on CTL epitopes. Virology Journal. 5: 99. PMID 18721481 DOI: 10.1186/1743-422X-5-99  0.52
2008 Venkatachari NJ, Buchanan WG, Ayyavoo V. Human immunodeficiency virus (HIV-1) infection selectively downregulates PD-1 expression in infected cells and protects the cells from early apoptosis in vitro and in vivo. Virology. 376: 140-53. PMID 18440040 DOI: 10.1016/j.virol.2008.03.015  0.52
2008 Majumder B, Venkatachari NJ, O'Leary S, Ayyavoo V. Infection with Vpr-positive human immunodeficiency virus type 1 impairs NK cell function indirectly through cytokine dysregulation of infected target cells. Journal of Virology. 82: 7189-200. PMID 18417583 DOI: 10.1128/JVI.01979-07  0.52
2007 Trible RP, Emert-Sedlak L, Wales TE, Ayyavoo V, Engen JR, Smithgall TE. Allosteric loss-of-function mutations in HIV-1 Nef from a long-term non-progressor. Journal of Molecular Biology. 374: 121-9. PMID 17920628 DOI: 10.1016/j.jmb.2007.09.009  0.52
2007 Schaubert KL, Price DA, Frahm N, Li J, Ng HL, Joseph A, Paul E, Majumder B, Ayyavoo V, Gostick E, Adams S, Marincola FM, Sewell AK, Altfeld M, Brenchley JM, et al. Availability of a diversely avid CD8+ T cell repertoire specific for the subdominant HLA-A2-restricted HIV-1 Gag p2419-27 epitope. Journal of Immunology (Baltimore, Md. : 1950). 178: 7756-66. PMID 17548613  0.52
2007 Majumder B, Venkatachari NJ, Schafer EA, Janket ML, Ayyavoo V. Dendritic cells infected with vpr-positive human immunodeficiency virus type 1 induce CD8+ T-cell apoptosis via upregulation of tumor necrosis factor alpha. Journal of Virology. 81: 7388-99. PMID 17475642 DOI: 10.1128/JVI.00893-06  0.52
2007 Janket ML, DeRicco JS, Borowski L, Ayyavoo V. Human immunodeficiency virus (HIV-1) Vpr induced downregulation of NHE1 induces alteration in intracellular pH and loss of ERM complex in target cells. Virus Research. 126: 76-85. PMID 17349711 DOI: 10.1016/j.virusres.2007.01.019  0.52
2007 Venkatachari NJ, Majumder B, Ayyavoo V. Human immunodeficiency virus (HIV) type 1 Vpr induces differential regulation of T cell costimulatory molecules: direct effect of Vpr on T cell activation and immune function. Virology. 358: 347-56. PMID 17023015 DOI: 10.1016/j.virol.2006.08.030  0.52
2006 Cui J, Tungaturthi PK, Ayyavoo V, Ghafouri M, Ariga H, Khalili K, Srinivasan A, Amini S, Sawaya BE. The role of Vpr in the regulation of HIV-1 gene expression. Cell Cycle (Georgetown, Tex.). 5: 2626-38. PMID 17172832 DOI: 10.4161/cc.5.22.3442  0.52
2006 Schafer EA, Venkatachari NJ, Ayyavoo V. Antiviral effects of mifepristone on human immunodeficiency virus type-1 (HIV-1): targeting Vpr and its cellular partner, the glucocorticoid receptor (GR). Antiviral Research. 72: 224-32. PMID 16889838 DOI: 10.1016/j.antiviral.2006.06.008  0.52
2006 Wheeler ED, Achim CL, Ayyavoo V. Immunodetection of human immunodeficiency virus type 1 (HIV-1) Vpr in brain tissue of HIV-1 encephalitic patients. Journal of Neurovirology. 12: 200-10. PMID 16877301 DOI: 10.1080/13550280600827377  0.52
2005 Miles MC, Janket ML, Wheeler ED, Chattopadhyay A, Majumder B, Dericco J, Schafer EA, Ayyavoo V. Molecular and functional characterization of a novel splice variant of ANKHD1 that lacks the KH domain and its role in cell survival and apoptosis. The Febs Journal. 272: 4091-102. PMID 16098192 DOI: 10.1111/j.1742-4658.2005.04821.x  0.52
2005 Majumder B, Janket ML, Schafer EA, Schaubert K, Huang XL, Kan-Mitchell J, Rinaldo CR, Ayyavoo V. Human immunodeficiency virus type 1 Vpr impairs dendritic cell maturation and T-cell activation: implications for viral immune escape. Journal of Virology. 79: 7990-8003. PMID 15956545 DOI: 10.1128/JVI.79.13.7990-8003.2005  0.52
2004 Thotala D, Schafer EA, Tungaturthi PK, Majumder B, Janket ML, Wagner M, Srinivasan A, Watkins S, Ayyavoo V. Structure-functional analysis of human immunodeficiency virus type 1 (HIV-1) Vpr: role of leucine residues on Vpr-mediated transactivation and virus replication. Virology. 328: 89-100. PMID 15380361 DOI: 10.1016/j.virol.2004.07.013  0.52
2004 Tungaturthi PK, Sawaya BE, Ayyavoo V, Murali R, Srinivasan A. HIV-1 Vpr: genetic diversity and functional features from the perspective of structure. Dna and Cell Biology. 23: 207-22. PMID 15142378 DOI: 10.1089/104454904773819798  0.52
2004 Janket ML, Manickam P, Majumder B, Thotala D, Wagner M, Schafer EA, Collman RG, Srinivasan A, Ayyavoo V. Differential regulation of host cellular genes by HIV-1 viral protein R (Vpr): cDNA microarray analysis using isogenic virus. Biochemical and Biophysical Research Communications. 314: 1126-32. PMID 14751250 DOI: 10.1016/j.bbrc.2004.01.008  0.52
2003 Majumder B, Gray B, McBurney S, Schaefer TM, Dentchev T, Mahalingam S, Reinhart TA, Ayyavoo V. Attenuated nef DNA vaccine construct induces cellular immune response: role in HIV-1 multiprotein vaccine. Immunology Letters. 89: 207-14. PMID 14556980 DOI: 10.1016/S0165-2478(03)00141-X  0.52
2003 Agadjanyan MG, Chattergoon MA, Holterman MJ, Monzavi-Karbassi B, Kim JJ, Dentchev T, Wilson D, Ayyavoo V, Montaner LJ, Kieber-Emmons T, Sekaly RP, Weiner DB. Costimulatory molecule immune enhancement in a plasmid vaccine model is regulated in part through the Ig constant-like domain of CD80/86. Journal of Immunology (Baltimore, Md. : 1950). 171: 4311-9. PMID 14530356  0.52
2003 Tungaturthi PK, Sawaya BE, Singh SP, Tomkowicz B, Ayyavoo V, Khalili K, Collman RG, Amini S, Srinivasan A. Role of HIV-1 Vpr in AIDS pathogenesis: relevance and implications of intravirion, intracellular and free Vpr. Biomedicine & Pharmacotherapy = BioméDecine & PharmacothéRapie. 57: 20-4. PMID 12642033 DOI: 10.1016/S0753-3322(02)00328-1  0.52
2000 Chattergoon MA, Kim JJ, Yang JS, Robinson TM, Lee DJ, Dentchev T, Wilson DM, Ayyavoo V, Weiner DB. Targeted antigen delivery to antigen-presenting cells including dendritic cells by engineered Fas-mediated apoptosis. Nature Biotechnology. 18: 974-9. PMID 10973219 DOI: 10.1038/79470  0.52
1997 Kim JJ, Ayyavoo V, Bagarazzi ML, Chattergoon M, Boyer JD, Wang B, Weiner DB. Development of a multicomponent candidate vaccine for HIV-1. Vaccine. 15: 879-83. PMID 9234538 DOI: 10.1016/S0264-410X(96)00260-5  0.52
1997 Mahalingam S, MacDonald B, Ugen KE, Ayyavoo V, Agadjanyan MG, Williams WV, Weiner DB. In vitro and in vivo tumor growth suppression by HIV-1 Vpr. Dna and Cell Biology. 16: 137-43. PMID 9052734  0.52
1997 Kim JJ, Ayyavoo V, Bagarazzi ML, Chattergoon MA, Dang K, Wang B, Boyer JD, Weiner DB. In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. Journal of Immunology (Baltimore, Md. : 1950). 158: 816-26. PMID 8992999  0.52
1994 Ugen KE, Wang B, Ayyavoo V, Agadjanyan M, Boyer J, Li F, Kudchodkar S, Lin J, Merva M, Fernandes L, Williams WV, Weiner DB. DNA inoculation as a novel vaccination method against human retroviruses with rheumatic disease associations Immunologic Research. 13: 154-162. PMID 7775806 DOI: 10.1007/BF02918276  0.52
Show low-probability matches.